Jul 14, 2026
2H2026 Catalyst Cluster
$ABOS, $EPRX, $MSLE, $OVID, $PMN, $XENE
Read piece →$XENE - Encode Coverage
Latest research notes and coverage for $XENE
Mar 20, 2026
Playbooks & Predictions: Xenon, Praxis, and Ovid
Read piece →Sep 3, 2025
Proof of Concept, FDA Alignment, and Durability: Ovid, Rezolute & Eupraxia
Read piece →Jul 17, 2025
Ovid and Xenon: Too Early to Draw Parallels?
$DCTH, $DRUG, $NKTR, $OVID, $SLNO, $XENE
Read piece →May 19, 2025
Decoding Q1: Insights on XENE, DCTH, RNXT, FENC
Read piece →Apr 16, 2025
Franchise Building: Xenon & Delcath
Read piece →Mar 6, 2025
Near-Term Data, Plump Balance Sheets & Calling It: Nektar, Ventyx & Xenon
Read piece →Nov 5, 2024
Epilepsy’s Hot, Can OVID “Seize” The Opportunity?
Read piece →Aug 14, 2024
Xenon (XENE), Delcath (DCTH), Protara (TARA) and Other Q2 Musings
$DCTH, $LLY, $NKTR, $PIRS, $TARA, $VERU, $VRTX, $XENE
Read piece →